A milestone is reached with the inclusion of 330 patients in the AGENT-study – opening up for the interim analysis
GOTHENBURG, Sweden, July 21, 2020 – Isofol Medical AB (http://isofol.se/en/) (publ) (Nasdaq First North Premier Growth Market: ISOFOL), today announced that […]